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The release of the neurotransmitter norepinephrine throughout the mammalian brain is important for modu-
lating attention, arousal, and cognition during many behaviors. Furthermore, disruption of norepinephrine-
mediated signaling is strongly associated with several psychiatric and neurodegenerative disorders in
humans, emphasizing the clinical importance of this system. Most of the norepinephrine released in the brain
is supplied by a very small, bilateral nucleus in the brainstem called the locus coeruleus. The goal of this
minireview is to emphasize the complexity of the locus coeruleus beyond its primary definition as a norepi-
nephrine-producing nucleus. Several recent studies utilizing innovative technologies highlight how the locus
coeruleus-norepinephrine system can now be targeted with increased accuracy and resolution, in order to
better understand its role in modulating diverse behaviors.Introduction
Throughout the day, our brains must constantly process a wide
variety of stimuli from our environment to decide what requires
our immediate attention. We may, however, only appreciate
the consequences of this ongoing neural process when it rea-
ches certain strengths; for instance, if we are suddenly startled,
or experience a stressful situation. Impressively, this continuous
modulation of our brain’s alertness and acuity is in large part
regulated by one of its smallest nuclei, the locus coeruleus
(LC). Despite comprising only a few thousand neurons, the LC
releases the neurotransmitter norepinephrine in many anatomi-
cally and functionally diverse brain regions. In mammals, the
LC is involved in modulating numerous behaviors, including
sleep/wake states, attention andmemory during cognitive tasks,
and stress response [1].
Despite these complex and diverse roles, several observa-
tions have led to the belief that the locus coeruleus-norepineph-
rine (LC-NE) system is largely homogeneous. The LC is
comprised of a densely packed population of cells (1600 cells
per LC in the rodent) with a common embryonic origin, all
of which produce norepinephrine [2]. In addition, populations
of LC neurons have been reported to exhibit synchronous
firing patterns and send extensive projections throughout the
brain and spinal cord to release norepinephrine [3–5]. Though
several decades of research have focused on understanding
LC anatomy and function, a central question in the field
remains: how does a small, seemingly homogeneous, structure
respond to diverse sensory stimuli and modulate neuronal activ-
ity in distinct brain regions, with a variety of behavioral conse-
quences?
A major reason for this lingering question comes from the
structure of the LC: its small size and shape make it challenging
to discretely target for ablation/inhibition studies without also
affecting nearby structures. Furthermore, because of its exten-
sive projection pattern, manipulations of the LC affect norepi-
nephrine signaling in many brain regions. Finally, chronic loss
of norepinephrine signaling, through LC ablation or transgenicCurrent Biology 25, R1051–R105knockout of genes crucial for norepinephrine synthesis, alters
signaling in several neuromodulatory pathways [6–8]. Together,
these limitations have made it challenging to address whether
discrete differences in LC anatomy or activity may underlie its
diverse roles in the mammalian brain.
Even with these limitations, heterogeneity within the LC-NE
system has been uncovered. While intriguing, the functional rele-
vance of these observations has been slow to develop. The goal
of this review is to highlight specific examples of organization
within this circuit that have been uncovered over the past 40
years to suggest its diversity beyond a single functioning unit.
With the rapid advancement of technologies that allow us to
characterize and target small populations of neurons in order
to uncover their identity, organization, and function, the time
has come to build on these findings to dissect the complexity
of this small but powerful nucleus.
Molecular Organization within the LC
Norepinephrine was one of the first neurotransmitters to be
identified, being discovered in the central nervous system by
Swedish physiologist Ulf von Euler in the 1940s, but it was the
experiments of Dahlstro¨m and Fuxe that identified the LC (group
A6) as the main source of norepinephrine in the brain [9,10]. Use
of immunolabeling techniques that were specific to dopamine-
b-hydroxylase (Dbh), the enzyme responsible for converting
dopamine to norepinephrine, allowed for precise detection of
norepinephrine+ neurons, including their extensive axonal pro-
jections [5]. These reagents also provided confirmation that the
LC is composed solely of norepinephrine+ neurons, supporting
the idea that it is a homogeneous structure.
Several studies, however, have observed that, while all LC
neurons contain norepinephrine, they have other distinct charac-
teristics that may provide heterogeneity to their function. At least
two types of norepinephrine+ cells, the large multipolar cells
(35 mm) and smaller fusiform cells (20 mm), have been
observed within the LC [11,12] (Figure 1A). While both cell types
are located throughout the LC, their distribution is biased, with6, November 2, 2015 ª2015 Elsevier Ltd All rights reserved R1051
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Figure 1. The LC-NE system has molecular
heterogeneity and receives inputs from
many brain areas to promote functional
diversity.
(A) Within the LC, norepinephrine+ cells with
different morphologies have biased locations
along the dorsal–ventral axis. These cells also
have biased projections to different brain regions
[11,26]. (B) While all LC neurons contain norepi-
nephrine, some also express other molecules that
may provide them with unique properties. Subsets
of LC-NE neurons co-release other peptides, such
as galanin and NPY, in addition to norepinephrine
[13]. Subsets of LC-NE neurons also express
different neurotransmitter receptors, which could
alter the properties and conditions of their activa-
tion [18]. (C) LC-NE neurons projecting to different
output sites have biased locations within the LC
structure along the dorsal–ventral (for hippocam-
pus-, cerebellum- and spinal cord-projecting) or
anterior–posterior (for thalamus- and hypothala-
mus-projecting) axes. Cortex- and amygdala-
projecting LC-NE neurons are located throughout
the LC [26–28]. It is unknown to what extent the characteristics represented in (A–C) overlap within populations of LC-NE neurons. (D) A sagittal schematic
illustrates the location of the LC in the brainstem (dark gray), and brain regions that provide the largest fraction of direct input to LC-NE neurons (arrows),
determined by trans-synaptic rabies tracing [28]. The thickness of the arrows represents the relative fraction of input neurons contributed by each region.
(E) Inputs from many brain regions converge onto individual LC-NE neurons [28]. Abbreviations: ARa1, adrenoceptor a1 subtype; ARa2, adrenoceptor a2
subtype; BNST, bed nucleus of the stria terminalis; Cb, cerebellum; CeA, central amygdala; Ctx, cortex; Hi, hippocampus; Hy, hypothalamus; IRN, intermediate
reticular nucleus; LC, locus coeruleus; LRN, lateral reticular nucleus; MRN, midbrain reticular nucleus; PAG, periaqueductal gray; PGRN/GRN, para-
gigantocellular/gigantocelluar nucleus; POA, preoptic area; PRN, pontine reticular nucleus; SVN, spinal vestibular nucleus; Th, thalamus. Panels D and E re-
printed by permission from Macmillan Publishers Ltd: Nature [28], copyright 2015.
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cells in the ventral LC [11].
In addition to morphological differences, several neuropep-
tides are expressed within subsets of LC neurons (Figure 1B).
The most abundant example is galanin (Gal), which is expressed
in up to 80% of LC neurons [13]. Release of Gal in the brain mod-
ulates many behaviors, such as wake/sleep states, nociception,
feeding, and parental behavior [14]. Neurons co-expressing Gal
and norepinephrine were found throughout the LC, but were
most densely localized to the dorsal and central LC sub-regions.
Gal expression in the LC has also been compared to Neuropep-
tide Y (NPY), which is co-expressed in a smaller population of LC
neurons (20%) restricted to the dorsal portion of LC [13].
While not directly confirmed, a small population of LC-NE neu-
rons has been hypothesized to co-express Gal and NPY. The
functional relevance of norepinephrine and neuropeptide co-
release from LC neurons is virtually uncharacterized, as is the
distribution of norepinephrine+/Gal+ and norepinephrine+/NPY+
axons throughout the brain. However, neuropeptide co-release
could in principle modify the effect of norepinephrine release at
specific output sites [15]. Many other neuropeptides have been
detected in small subsets of neurons in the LC, though their
role is unclear [16].
LC neurons also contain many neurotransmitter receptors,
which, if variably expressed, could promote important differ-
ences in how individual LC neurons respond to similar inputs.
For instance, the LC itself is responsive to norepinephrine
release, and LC-NE neurons contain several adrenoceptor sub-
types, most abundantly a2, with lower expression of a1 [17].
These receptors may be differentially localized within the LC,
as a1 binding sites, detected by radioactive ligand, were more
abundant in the anterior portion of the LC, while a2 binding sites
were more dense in the posterior LC (Figure 1B) [18]. Also, these
adrenoceptor sub-types are coupled with different G proteinR1052 Current Biology 25, R1051–R1056, November 2, 2015 ª2015signaling pathways that could promote opposing actions on local
LC activity, depending on which receptors were activated [19].
Nicotinic acetylcholine receptors (nAChRs) are also highly ex-
pressed within the LC, where application of acetylcholine and
nicotine were shown to depolarize LC neurons and increase their
firing rate [20]. Single cell RT-PCR of LC neurons suggested that
nAChRswere differentially expressed in these cells, and could be
classified into twogroups: small cells, with higher levels of a3 and
b4 mRNAs, and large cells, with more mRNA of the a6 and b3
subtypes. These two classes of LC neurons displayed different
strength of responses upon nicotine application [21]. Other
neurotransmitter and neuropeptide receptors, such as GABA,
orexin/hypocretin, and opioid receptors, are present in LC neu-
rons, but it is unclear if they are differentially expressed [22–24].
As these findings indicate, neurons within the LC are much
more molecularly diverse than their primary definition as norepi-
nephrine-producing cells. It is surprising, however, that while
many of these molecules have been identified in the LC for de-
cades, almost nothing is known regarding their roles there.
With the development of public gene expression databases,
such as the Allen Brain Atlas and Eurexpress, as well as technol-
ogies that allow high-resolution sequencing of discrete cell pop-
ulations, our awareness of the LC’s molecular diversity will only
grow. Meanwhile, tools for exploring the function of these mole-
cules are also rapidly advancing. For instance, the recent devel-
opment of a transgenic mouse expressing Flp recombinase in
norepinephrine+ neurons now allows researchers to target
molecularly diverse norepinephrine+ cell populations in the brain
using intersectional strategies, in order to precisely characterize
their function [2].
Anatomical Organization of the LC-NE System
In addition to its molecular composition, the anatomical connec-
tivity between the LC and the rest of the brain is crucial for properElsevier Ltd All rights reserved
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olfactory bulb, nearly all brain regions contain Dbh+ axons; the
exceptions include the striatum, globus pallidus, nucleus ac-
cumbens, and substantia nigra, all of which are rich for dopamine
neuron axonal projections or cell bodies. The lack of LC projec-
tions within these regions suggests a division of labor between
the two types of catecholamine neurons [11]. Separate experi-
ments, where radioisotopes were injected directly into the LC,
confirmed that it sends extensive projections to the forebrain,
cerebellum, brainstem, and spinal cord [25].
But while these studies demonstrated that the output projec-
tions of the LC are broad, they provided only limited information
about the organization of these efferent projections, and did not
address if LC neurons project homogeneously throughout the
nervous system, or if sub-populations project to specific targets.
The use of retrograde tracers was an important step in address-
ing these issues. By injecting the retrograde dye horseradish
peroxidase (HRP) into brain regions receiving LC input, several
groups observed a similar phenomenon: that certain cells within
the LC are topographically organized based on their output
target (Figure 1C). In general, LC neurons projecting to forebrain
regions (such as hippocampus and septum) are located in dorsal
LC, while cerebellum- and spinal cord-projecting LC neurons are
located more ventrally. Output-specific organization was also
observed along the anterior-posterior axis, with hypothalamic-
projecting LC cells located anteriorly, thalamic-projecting cells
located posteriorly, and cortical and amygdala-projecting cells
scattered throughout the LC [26–28]. One group also noted
that this output-dependent topography corresponded with
different cell morphologies in the LC [26].
For the most part, it is not known how this topographic orga-
nization relates to LC function, but a recent study [29] highlights
how we can begin to understand this relationship using viral
reagents and optogeneticmethods. To optically activate popula-
tions of LC-NE neurons, lentivirus expressing channelrhodop-
sin2 (ChR2) under the control of a catecholaminergic-specific
promoter was injected into the LC of rats. Upon illumination of
the LC, roughly half of the animals displayed an antinociceptive
effect when thermal heat was applied to their paw, while the
other half had a pronociceptive response. Post-hoc histological
analysis revealed that animals with antinociceptive responses
had more ChR2+ LC-NE neurons located in the ventral LC, while
pronociceptive animals had more ChR2+ neurons in the dorsal
LC [29]. Hence, activation of dorsal or ventral biased populations
of LC-NE neurons can modulate distinct behaviors in the rodent.
But the topography of norepinephrine+ somata within the LC is
only one component of its output organization: of equal impor-
tance is an understanding of how the LC axons themselves are
organized; specifically, do populations of LC neurons contact
discrete brain regions, or collateralize to simultaneously reach
multiple targets?
Classic studies approached this question by injecting a pair of
retrograde tracers into two LC projection sites, such as cortex
and cerebellum, or hippocampus and thalamus. It was observed
that a substantial portion of LC neurons were labeled by both
tracers, indicating that they sent projections to both injection
sites and supporting the idea that LC neurons collateralize over
long distances throughout the brain [30–32]. Recent work, how-
ever, has found that LC collateralization is more segregated inCurrent Biology 25, R1051–R105cortical areas [33]. While these studies provide insight regarding
LC output organization, they only assess collateralization of LC
neurons between two brain regions, and different tracers may
have different labeling efficiencies for LC neurons. To circumvent
these limitations, a recent study utilized canine-adenovirus type
2 (CAV), which robustly infects neurons via their axon terminals,
to visualize the output organization of LC-NE neuron populations
projecting to many regions throughout the mouse brain [28]. LC
output was found to be highly divergent, yet the density of
labeled LC axons within certain brain regions was not completely
homogeneous. Therefore, while overall the LC-NE system collat-
eralizes broadly (an important characteristic with regard to its
role in modulating entire brain states), small populations of LC
neurons may innervate certain targets more selectively.
Deciphering the organization of inputs received by the LC is
another crucial component in understanding how its activity is
regulated during behaviors. By injecting retrograde tracers
directly into the LC, several groups reported that the LC receives
input frommany brain regions, while others argued that its inputs
were much more restricted [34,35]. These discrepancies are
likely explained by two limitations of retrograde tracers: they
can be taken up by axons-in-passage as well as axonal termi-
nals, resulting in labeling of ‘inputs’ that are not directly con-
nected to the LC; and uptake is restricted to the injection site
at the LC cell bodies, so distant inputs onto dendritic arbors
would be missed.
Only recently was the brain-wide synaptic input onto LC neu-
rons more definitively determined through the use of trans-syn-
aptic rabies viral tracing methods (Figure 1D) [28]. In contrast
to classic studies that reported limited inputs, rabies tracing re-
vealed that up to 111 different brain regions send direct input,
with varying number of input neurons, to the LC. A simulation
analysis of the tracing data suggested that individual LC-NE neu-
rons receive input from 9–15 different brain regions as a lower
bound, indicating that the inputs received by the LC are largely
integrative (Figure 1E). This study also introduced a new method
called ‘tracing the relationship between input and output’ (TRIO)
and cell-type-specific TRIO (cTRIO), which restricts trans-syn-
aptic tracing to subsets of neurons based on their cell-type
and projection pattern. Using TRIO and cTRIO, it was found
that LC-NE neurons projecting to diverse brain regions received
mostly similar input. This result is consistent with the idea that the
LC-NE system integrates and broadcasts information widely to
modulate brain states. Discrete differences in input–output
connectivity were observed, however, for certain LC-NE sub-cir-
cuits, which support previous observations that the LC is not
entirely homogeneous [28].
These findings suggest that mechanisms exist beyond the
anatomical organization of the LC-NE system that help it to
generate diverse behavioral responses. In support of this, classic
studies have shown that the firing rates of LC-NE neurons in-
crease when the animal is aroused [4,36]. Furthermore, the fre-
quency with which LC neurons fire is positively correlated with
their synchrony [37]. But it was only recently, through the use
of optogenetic methods, that the causal role of variable LC
firing to mediate specific behaviors was directly demonstrated
(Figure 2A) [38,39]. In one study [38], the authors closely
controlled the firing rate of LC-NE neurons in awake-behaving
mice to show that LC activation maintains the duration of wake6, November 2, 2015 ª2015 Elsevier Ltd All rights reserved R1053
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Figure 2. Variability in LC firing rates, and
in the local environment where
norepinephrine is released, promotes
functional diversity.
A sagittal schematic illustrates projections from
the LC to almost all brain regions (arrows) [11].
(A) Optogenetic methods have been used to
demonstrate how differences in LC firing rates
generate unique behaviors in the mouse. For
instance, induction of tonic or phasic firing in the
LC promotes wakefulness [38], while high-fre-
quency tonic firing can induce anxiety-like and
aversive behaviors in the mouse [39].
(B) Differences in post-synaptic receptor expres-
sion in neurons targeted by LC-NE axons allow
target cells to be differentially activated by
norepinephrine. Interspersed ChAT+ and GABA+
neurons in the basal forebrain receive input from
the LC and project to the cortex. When norepi-
nephrine is released, the ChAT+ neurons, which
express the a1 and b1 adrenoceptors that pro-
mote excitation, release more acetylcholine in
the cortex to promote arousal. Simultaneously,
release of norepinephrine suppresses the GABA+
neurons, which express inhibitory a2 adreno-
ceptors. These neurons normally promote sleep
by releasing GABA in the cortex [41–45]. (C) Dif-
ferential presynaptic regulation of neurotrans-
mitter release (for example, via axo-axonic
synapses) can promote differences in downstream signaling from the same LC-NE neurons. It is unknown whether this phenomenon occurs within the LC-NE
system, but examples can be found for pre-synaptic gating in other neuronal types in the cortex, hippocampus [46], and dorsal raphe [47]. Abbreviations: Amy,
amygdala; BF, basal forebrain; Cb, cerebellum; ChAT, choline acetyltransferase; Ctx, cortex; GABA, g-aminobutyric acid; Hi, hippocampus; Hy, hypothalamus;
LC, locus coeruleus; NE, norepinephrine; Th, thalamus. Sagittal schematic reprinted by permission from Macmillan Publishers Ltd: Nature [28], copyright 2015.
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They also observed differences in locomotor activity and behav-
ioral arrest in themice, depending on the pattern (tonic or phasic)
and length of the optogenetic stimulation applied to the LC. A
second study [39] also used optogenetics to manipulate LC ac-
tivity during stress-induced behaviors. In this way, the authors
demonstrated that high-frequency tonic, but not phasic, activa-
tion of the LC could elicit anxiety-like and aversive behaviors.
They also found that chemogenetic inhibition of the LC during
stressful stimuli prevented subsequent anxiety-like behavior,
an important insight for developing effective treatments for
stress-related disorders.
Together, these findings nicely highlight the importance of
distinct LC firing patterns for the generation of different behav-
iors. The input connectivity that drives these differences is still
largely unknown, but the generation of tools that now allow
one to manipulate, record, and trace the connection of specific
subsets of neurons within the LC should help clarify these
outstanding issues.
Effects of LC-mediated Norepinephrine Release at
Output Sites
Several characteristics, such as the molecular composition and
topographical organization of the LC, and subtle differences in
its anatomical connectivity, suggest that while the LC-NE system
is largely integrative, it does not perform completely homoge-
neously. Even if LC-NE neurons are homogeneous in their axonal
projections anatomically, however, there are several mecha-
nisms by which they could differentially affect the physiology of
their targets. While much remains to be investigated, the best
characterized of these phenomena is the differential expression
of post-synaptic adrenoceptors.R1054 Current Biology 25, R1051–R1056, November 2, 2015 ª2015For instance, post-synaptic adrenoceptor diversity in the basal
forebrain (including the medial septal nucleus, medial preoptic
nucleus, and substantia innominata) allows the LC to promote
both excitation and inhibition of target cells that are important
for wakefulness (Figure 2B). The basal forebrain contains inter-
spersed populations of excitatory/modulatory cholinergic neu-
rons and inhibitory GABAergic neurons, which send parallel
projections to the cortex to mediate arousal behaviors [40,41].
The cholinergic population is activated during arousal, while
the GABAergic population is activated during sleep states
[42,43]. Release of norepinephrine from LC terminals in the basal
forebrain simultaneously activates the cholinergic neurons,
which express a1 and b1 adrenoceptors, while inhibiting the
GABAergic neurons, which express a2 adrenoceptors [44,45].
In this way, LC activation leads to norepinephrine release in
the basal forebrain that modulates cholinergic and GABAergic
neurons in opposing manners, which act in a concerted fashion
to promote arousal.
Another potential mechanism in which similar LC-NE neurons
could differentially affect their targets would be through local
presynaptic regulation of norepinephrine release at target sites
(Figure 2C). Such a phenomenon has yet to be uncovered
for the LC-NE system, but other examples of axo-axonic regula-
tion of neurotransmitter release have been described in the
brain [46,47].
Implications for Brain Disorders
Though the findings summarized in this minireview focus on the
basic biological mechanisms underlying LC organization and
function, our increased understanding of this system also greatly
impacts our progress in treating several neurological diseases.
For instance, drugs that block the re-uptake of norepinephrineElsevier Ltd All rights reserved
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disorders such as anxiety and depression, suggesting involve-
ment of the LC-NE system in these conditions [48]. But the suc-
cess of these treatments can vary and come with many negative
side effects, likely due to their broad action on norepinephrine
signaling in the nervous system. LC dysfunction is also strongly
correlated with several neurodegenerative disorders, such as
Alzheimer’s disease, Parkinson’s disease, and multiple scle-
rosis, where LC-NE neurons undergo selective and early degen-
eration [49,50]. That the LC is implicated in such a variety of
psychiatric and neurological disorders emphasizes both its
importance and complexity within the brain. While many studies
over the past 40 years have contributed to our understanding of
how the LC-NE system is organized in the brain, the recent
development of genetic, viral, and optogenetic tools now allow
us to more precisely determine the functional significance of
these findings, and apply them to improve our understanding
and treatment of these disorders.REFERENCES
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